» Articles » PMID: 22247870

Spectrophotometric Methods for the Determination of Letrozole in Bulk and Pharmaceutical Dosage Forms

Overview
Date 2012 Jan 17
PMID 22247870
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Ultraviolet (UV), first derivative, second derivative, and AUC-spectrophotometric methods for the determination of letrozole in pharmaceutical formulations have been developed. For UV-spectrophotometry, the standard solutions were measured at 240.0 nm. The linearity ranges were found to be 0.25-20.0 μgml(-1) in methanol and the regression equation was A=1.20×10(-1)C+2.22×10(-2)(r(2)=0.9994). For the first derivative spectrophotometry, the response (dA/dλ) of standard solutions was measured at 224.0 nm. The calibration curve was constructed by plotting dA/dλ values against concentrations 0.25-20.0 μgml(-1), of letrozole. The regression equation of the linear calibration graph was calculated as D(1)=3.89×10(-3)C+1.85×10(-4)(r(2)=0.9987). For the second derivative spectrophotometry, the response (d(2)A/dλ(2)) of standard solutions was measured at 241.0 nm. The calibration curve was constructed by plotting d(2)A/dλ(2) values against concentrations 0.5-20.0 μgml(-1) of letrozole standards in methanol. The regression equation of the linear calibration graph was calculated as D(2)=-1.59×10(-3)C-4.66×10(-4)(r(2)=0.9985). The AUC-spectrophotometric method was based on the calculation of Area under Curve (AUC), for analysis of letrozole in the wavelength range of 235.0-245.0 nm. The calibration curve was constructed by plotting AUC values against concentrations 0.25-20.0 μgml(-1), of letrozole. The regression equation of the linear calibration graph was calculated as AUC=1.132C+0.2153 (r(2)=0.9994). The methods were validated by following the analytical performance parameters suggested by the International Conference on Harmonization (ICH). All validation parameters were within the acceptable range. The developed methods were successfully applied to estimate the amount of letrozole in pharmaceutical formulations.

Citing Articles

Stability-indicating spectrophotometric manipulations for the determination of Letrozole in the presence of its alkali-induced degradation products; towards whiteness and ChlorTox scale perspectives.

El-Fatah N, Fouad M, Hegazy M, El-Sayed G BMC Chem. 2025; 19(1):63.

PMID: 40057722 PMC: 11890550. DOI: 10.1186/s13065-025-01416-2.


Synthesis of vitamin D3 loaded ethosomes gel to cure chronic immune-mediated inflammatory skin disease: physical characterization, in vitro and ex vivo studies.

Mehmood Y, Shahid H, Ahmed S, Khursheed A, Jamshaid T, Jamshaid M Sci Rep. 2024; 14(1):23866.

PMID: 39394201 PMC: 11470002. DOI: 10.1038/s41598-024-72951-6.


A comparative study of green solid contact ion selective electrodes for the potentiometric determination of Letrozole in dosage form and human plasma.

Alqirsh S, Magdy N, Abdel-Ghany M, El Azab N Sci Rep. 2023; 13(1):20187.

PMID: 37980444 PMC: 10657372. DOI: 10.1038/s41598-023-47240-3.


Novel Hydrolytic Degradable Crosslinked Interpenetrating Polymeric Networks (IPNs): An Efficient Hybrid System to Manage the Controlled Release and Degradation of Misoprostol.

Mehmood Y, Shahid H, Barkat K, Arshad N, Rasul A, Uddin M Gels. 2023; 9(9).

PMID: 37754378 PMC: 10529051. DOI: 10.3390/gels9090697.


Amikacin-Loaded Chitosan Hydrogel Film Cross-Linked with Folic Acid for Wound Healing Application.

Mehmood Y, Shahid H, Arshad N, Rasul A, Jamshaid T, Jamshaid M Gels. 2023; 9(7).

PMID: 37504430 PMC: 10379863. DOI: 10.3390/gels9070551.


References
1.
Lamb H, Adkins J . Letrozole. A review of its use in postmenopausal women with advanced breast cancer. Drugs. 1999; 56(6):1125-40. DOI: 10.2165/00003495-199856060-00020. View

2.
Marfil F, Pineau V, Sioufi A, Godbillon S . High-performance liquid chromatography of the aromatase inhibitor, letrozole, and its metabolite in biological fluids with automated liquid-solid extraction and fluorescence detection. J Chromatogr B Biomed Appl. 1996; 683(2):251-8. DOI: 10.1016/0378-4347(96)00118-1. View

3.
Pfister C, Duval M, Godbillon J, Gosset G, Gygax D, Marfil F . Development, application and comparison of an enzyme immunoassay and a high-performance liquid chromatography method for the determination of the aromatase inhibitor CGS 20,267 in biological fluids. J Pharm Sci. 1994; 83(4):520-4. DOI: 10.1002/jps.2600830415. View

4.
Mondal N, Pal T, Ghosal S . Development and validation of RP-HPLC method to determine letrozole in different pharmaceutical formulations and its application to studies of drug release from nanoparticles. Acta Pol Pharm. 2009; 66(1):11-7. View

5.
Iveson T, Smith I, Ahern J, Smithers D, Trunet P, Dowsett M . Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in healthy postmenopausal women. J Clin Endocrinol Metab. 1993; 77(2):324-31. DOI: 10.1210/jcem.77.2.8345035. View